Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor‐κB/MDR1 pathway in colorectal cancer

Recent studies have shown that MDR could be induced by the high stemness of cancer cells. In a previous study, we found bufalin could reverse MDR and inhibit cancer cell stemness in colorectal cancer, but the relationship between them was unclear. Here we identified overexpressing CD133 increases le...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Sci
Egile Nagusiak: Zhan, Yueping, Qiu, Yanyan, Wang, Haijing, Wang, Ziyuan, Xu, Jian, Fan, Guohua, Xu, Jianhua, Li, Wei, Cao, Yijun, Le, Van‐Minh, Ly, Hai‐Trieu, Yuan, Zeting, Xu, Ke, Yin, Peihao
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2020
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7226280/
https://ncbi.nlm.nih.gov/pubmed/32058643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14345
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak